Market Overview

Benchmark Downgrades Autohome On Growth Outlook Concerns Amid Weakness In Auto Sales

Share:
Benchmark Downgrades Autohome On Growth Outlook Concerns Amid Weakness In Auto Sales

Continuous weakness in auto sales is likely to limit OEM ad spending across all channels, which adversely impacts Autohome Inc’s (NYSE: ATHM) growth outlook, according to Benchmark.

The Analyst

Benchmark’s Fawne Jiang downgraded Autohome from Buy to Hold.

The Thesis

Auto dealers in China witnessed substantial pressure in 2Q 2019 and have continued to suffer deteriorating profitability due to macro environment challenges, Jiang said in the note. He added that the uncertainties around dealer growth could increase in the near to intermediate term.

Autohome’s margins could come under pressure as the company may be compelled to absorb more costs in an effort to help its OEM and dealer partners, Jiang mentioned. He explained that while this strengthens Autohome’s long-term relationships, it casts clouds over the company’s earnings outlook.

The analyst reduced the EPS estimates for FY2019 and FY2020 to $4.20 and $4.57, respectively.

Price Action

Shares of Autohome traded around $82.04 on Friday.

Related Links:

Benzinga's Top Upgrades, Downgrades For July 19, 2019

26 Stocks Moving In Wednesday's Pre-Market Session

Latest Ratings for ATHM

DateFirmActionFromTo
Jul 2019DowngradesBuyHold
Jul 2019DowngradesBuyHold
Jun 2019Initiates Coverage OnOutperform

View More Analyst Ratings for ATHM
View the Latest Analyst Ratings

Posted-In: Benchmark Fawne JiangAnalyst Color Downgrades Analyst Ratings

 

Related Articles (ATHM)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
IQDowngrades
IQDowngrades21.0
COTYMaintains9.0
FNMaintains60.0
NNNMaintains57.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Midatech Pharma Rallies On Positive MTX102 Results

Acreage Holdings Names Former MedMen Exec As Its New CIO